USA - NYSE:MCK - US58155Q1031 - Common Stock
The current stock price of MCK is 787.82 USD. In the past month the price increased by 13.03%. In the past year, price increased by 55.26%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
COR | CENCORA INC | 21.14 | 63.47B | ||
CAH | CARDINAL HEALTH INC | 19.09 | 37.36B | ||
HSIC | HENRY SCHEIN INC | 13.72 | 7.75B | ||
AHCO | ADAPTHEALTH CORP | 30.55 | 1.28B | ||
AHG | AKSO HEALTH GROUP | N/A | 911.67M | ||
OMI | OWENS & MINOR INC | 3.38 | 381.57M | ||
ATPC | AGAPE ATP CORP | N/A | 60.76M | ||
WGRX | WELLGISTICS HEALTH INC | N/A | 39.26M | ||
COSM | COSMOS HEALTH INC | N/A | 31.42M | ||
VRAX | VIRAX BIOLABS GROUP LTD | N/A | 2.85M | ||
POM | POMDOCTOR LTD - ADR | N/A | 506.92M |
McKesson Corp. engages in providing healthcare services. The company is headquartered in Irving, Texas and currently employs 43,000 full-time employees. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. The company also offers oncology and specialty solutions.
MCKESSON CORP
6555 State Highway 161
Irving TEXAS 75039 US
CEO: Brian S. Tyler
Employees: 48000
Phone: 19724464800
The current stock price of MCK is 787.82 USD. The price increased by 0.23% in the last trading session.
The exchange symbol of MCKESSON CORP is MCK and it is listed on the New York Stock Exchange, Inc. exchange.
MCK stock is listed on the New York Stock Exchange, Inc. exchange.
22 analysts have analysed MCK and the average price target is 842.54 USD. This implies a price increase of 6.95% is expected in the next year compared to the current price of 787.82. Check the MCKESSON CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MCKESSON CORP (MCK) has a market capitalization of 97.99B USD. This makes MCK a Large Cap stock.
MCKESSON CORP (MCK) currently has 48000 employees.
MCKESSON CORP (MCK) has a support level at 785.99 and a resistance level at 787.83. Check the full technical report for a detailed analysis of MCK support and resistance levels.
The Revenue of MCKESSON CORP (MCK) is expected to grow by 12.67% in the next year. Check the estimates tab for more information on the MCK EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MCKESSON CORP (MCK) has a dividend yield of 0.42%. The yearly dividend amount is currently 2.71. Check the full fundamental report for a detailed analysis of MCK dividend history, reliability and sustainability.
MCKESSON CORP (MCK) will report earnings on 2025-11-05, after the market close.
The PE ratio for MCKESSON CORP (MCK) is 23.53. This is based on the reported non-GAAP earnings per share of 33.48 and the current share price of 787.82 USD. Check the full fundamental report for a full analysis of the valuation metrics for MCK.
The outstanding short interest for MCKESSON CORP (MCK) is 1.48% of its float. Check the ownership tab for more information on the MCK short interest.
ChartMill assigns a technical rating of 10 / 10 to MCK. When comparing the yearly performance of all stocks, MCK is one of the better performing stocks in the market, outperforming 87.8% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to MCK. MCK has only an average score on both its financial health and profitability.
Over the last trailing twelve months MCK reported a non-GAAP Earnings per Share(EPS) of 33.48. The EPS increased by 19.44% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 0.84% | ||
ROA | 3.89% | ||
ROE | N/A | ||
Debt/Equity | N/A |
22 analysts have analysed MCK and the average price target is 842.54 USD. This implies a price increase of 6.95% is expected in the next year compared to the current price of 787.82.
For the next year, analysts expect an EPS growth of 14.76% and a revenue growth 12.67% for MCK